- Home
- MNOV vs ZYXI Comparison
MNOV vs ZYXI Comparison
Compare MNOV & ZYXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNOV
- ZYXI
- Stock Information
- Founded
- MNOV 2000
- ZYXI 1996
- Country
- MNOV United States
- ZYXI United States
- Employees
- MNOV N/A
- ZYXI N/A
- Industry
- MNOV Biotechnology: Pharmaceutical Preparations
- ZYXI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- MNOV Health Care
- ZYXI Health Care
- Exchange
- MNOV Nasdaq
- ZYXI Nasdaq
- Market Cap
- MNOV 68.2M
- ZYXI 72.3M
- IPO Year
- MNOV 2005
- ZYXI N/A
- Fundamental
- Price
- MNOV $1.35
- ZYXI $2.49
- Analyst Decision
- MNOV Strong Buy
- ZYXI Buy
- Analyst Count
- MNOV 2
- ZYXI 3
- Target Price
- MNOV $7.00
- ZYXI $5.50
- AVG Volume (30 Days)
- MNOV 48.4K
- ZYXI 132.8K
- Earning Date
- MNOV 08-07-2025
- ZYXI 07-31-2025
- Dividend Yield
- MNOV N/A
- ZYXI N/A
- EPS Growth
- MNOV N/A
- ZYXI N/A
- EPS
- MNOV N/A
- ZYXI N/A
- Revenue
- MNOV N/A
- ZYXI $172,401,000.00
- Revenue This Year
- MNOV N/A
- ZYXI N/A
- Revenue Next Year
- MNOV N/A
- ZYXI $19.55
- P/E Ratio
- MNOV N/A
- ZYXI N/A
- Revenue Growth
- MNOV N/A
- ZYXI N/A
- 52 Week Low
- MNOV $1.12
- ZYXI $1.66
- 52 Week High
- MNOV $2.55
- ZYXI $9.42
- Technical
- Relative Strength Index (RSI)
- MNOV 54.24
- ZYXI 53.86
- Support Level
- MNOV $1.31
- ZYXI $2.46
- Resistance Level
- MNOV $1.50
- ZYXI $2.82
- Average True Range (ATR)
- MNOV 0.06
- ZYXI 0.15
- MACD
- MNOV 0.02
- ZYXI 0.02
- Stochastic Oscillator
- MNOV 48.28
- ZYXI 57.14
About MNOV Medicinova Inc
MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's current strategy is to focus its development activities on therapeutics for neurological disorders and fibrotic diseases.
About ZYXI Zynex Inc.
Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufactures, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company operates business as one operating segment which includes two revenue types: Devices and Supplies. Its markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave, and others.